91 related articles for article (PubMed ID: 29351921)
1. Inhibitory Effects of Endogenous Linoleic Acid and Glutaric Acid on the Renal Glucuronidation of Berberrubine in Mice and on Recombinant Human UGT1A7, 1A8, and 1A9.
Yang N; Li S; Yan C; Sun R; He J; Xie Y; Peng Y; Wang G; Aa J
Mol Pharmacol; 2018 Mar; 93(3):216-227. PubMed ID: 29351921
[TBL] [Abstract][Full Text] [Related]
2. In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.
Yang N; Sun RB; Chen XL; Zhen L; Ge C; Zhao YQ; He J; Geng JL; Guo JH; Yu XY; Fei F; Feng SQ; Zhu XX; Wang HB; Fu FH; Aa JY; Wang GJ
Acta Pharmacol Sin; 2017 Mar; 38(3):351-361. PubMed ID: 28042874
[TBL] [Abstract][Full Text] [Related]
3. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
5. High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile.
Yang N; Sun R; Zhao Y; He J; Zhen L; Guo J; Geng J; Xie Y; Wang J; Feng S; Fei F; Liao X; Zhu X; Wang H; Fu F; Aa J; Wang G
Environ Toxicol Pharmacol; 2016 Sep; 46():319-327. PubMed ID: 27525563
[TBL] [Abstract][Full Text] [Related]
6. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
[TBL] [Abstract][Full Text] [Related]
7. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
Ruan JQ; Yan R
Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
[TBL] [Abstract][Full Text] [Related]
8. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
9. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases.
Hanioka N; Kinashi Y; Tanaka-Kagawa T; Isobe T; Jinno H
Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.
Sakaguchi K; Green M; Stock N; Reger TS; Zunic J; King C
Arch Biochem Biophys; 2004 Apr; 424(2):219-25. PubMed ID: 15047194
[TBL] [Abstract][Full Text] [Related]
12. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
Rowland A; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
[TBL] [Abstract][Full Text] [Related]
13. Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.
Sun H; Ma Z; Lu D; Wu B
J Pharm Sci; 2015 Jul; 104(7):2369-77. PubMed ID: 25941108
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Gaganis P; Miners JO; Knights KM
Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
[TBL] [Abstract][Full Text] [Related]
15. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
Kerdpin O; Knights KM; Elliot DJ; Miners JO
Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
[TBL] [Abstract][Full Text] [Related]
17. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
[TBL] [Abstract][Full Text] [Related]
18. Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.
Margaillan G; Rouleau M; Fallon JK; Caron P; Villeneuve L; Turcotte V; Smith PC; Joy MS; Guillemette C
Drug Metab Dispos; 2015 Apr; 43(4):611-9. PubMed ID: 25650382
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2004 Nov; 25(8):339-44. PubMed ID: 15378558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
